David Wayne Nichols Magenta Therapeutics, Inc. (MGTA) insider trading activity

MGTA Quotes by TradingView

David Wayne Nichols is Chief Technical Officer of Magenta Therapeutics, Inc.. Currently has a direct ownership of 14,306 shares of MGTA, which is worth approximately $0. The most recent transaction as insider was on Sep 16, 2021, when has been sold 5,694 shares (Common Stock) at a price of $6.73 per share, resulting in proceeds of $38,321. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.3K
0% 3M change
0% 12M change
Total Value Held $0

David Wayne Nichols Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 16 2021
SELL
Open market or private sale
$38,321 $6.73 p/Share
5,694 Reduced 28.47%
14,306 Common Stock
Sep 14 2021
BUY
Grant, award, or other acquisition
-
20,000 Added 50.0%
20,000 Common Stock
DWN

David Wayne Nichols

Chief Technical Officer
Cambridge, MA

Track Institutional and Insider Activities on MGTA

Follow Magenta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Insider Trading

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

News

Receive news related to Magenta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MGTA